EpiVacCorona vaccine trials have been completed among people over 65 years old

“We are waiting for this (permission to vaccinate people over 65) literally from day to day.

The studies have been completed, and all the documents have been duly submitted, "TASS quotes Popova.

Earlier, the State Research Center for Virology and Biotechnology "Vector" sent the results of the first and second phases of clinical trials of the EpiVacCorona vaccine to foreign scientific journals.